Mayne Pharma LLC
7Patents
7Active
7Granted
43Portfolio score
Filing activity: Feb 3, 2008 → Dec 1, 2022 · 2 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10857159B2 | Halobetasol foam composition and method of use thereof | Human Necessities | 0 | Active |
| US12350255B2 | Stabilized oxymetazoline formulations and their uses | Human Necessities | 0 | Active |
| US11020407B2 | Corticosteroid containing foam compositions and method of manufacture thereof | Performing Operations; Transporting | 0 | Active |
| US10688071B2 | Topical foam composition | Human Necessities | 0 | Active |
| US12350382B2 | Method for preparing particles comprising metal oxide coating and particles with metal oxide coating | Emerging Cross-Sectional Technologies | 0 | Active |
| US10568859B2 | Topical foam composition | Human Necessities | 0 | Active |
| US12357602B2 | Compositions comprising encapsulated tretinoin | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.